Intratympanic gentamicin for Ménière’s disease New
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intratympanic Gentamicin for Ménière’s Disease New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433008/all/Intratympanic_gentamicin_for_Ménière_s_disease_New. Accessed 03 June 2023.
Intratympanic gentamicin for Ménière’s disease New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433008/all/Intratympanic_gentamicin_for_Ménière_s_disease_New. Accessed June 3, 2023.
Intratympanic gentamicin for Ménière’s disease New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433008/all/Intratympanic_gentamicin_for_Ménière_s_disease_New
Intratympanic Gentamicin for Ménière’s Disease New [Internet]. In: Cochrane Abstracts. [cited 2023 June 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433008/all/Intratympanic_gentamicin_for_Ménière_s_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intratympanic gentamicin for Ménière’s disease New
ID - 433008
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433008/all/Intratympanic_gentamicin_for_Ménière_s_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -